EUVIMEDEUVIMED entdecken
Open Access

AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy

Benedette Cuffari

Journal of Medical Internet Research · 09.07.2026 · 28 · e106201-e106201

DOI: 10.2196/106201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 09.07.2026. Verfasst von Benedette Cuffari. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Precision Medicine, Neoplasms, Machine Learning. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computing advances are helping improve the precision and effectiveness of cancer treatment. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent AI applications for radiopharmaceutical therapy, as well as the current state of the field and its future potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsPrecision MedicineNeoplasmsMachine LearningArtificial IntelligenceHumans

Stichwörter der Autor:innen

personalized medicinedeep learningradioligand discoveryradiopharmaceuticalstheranostics

Substanzen

Radiopharmaceuticals

Zitieren

APA

Cuffari, B. (2026). AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research, 28, e106201-e106201. https://doi.org/10.2196/106201

Vancouver

Cuffari B. AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research. 2026;28:e106201-e106201. doi:10.2196/106201

BibTeX
@article{Cuffari2026,
  author = {Cuffari, Benedette},
  title = {AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e106201--e106201},
  doi = {10.2196/106201}
}
Kostenlos starten →